Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,854 | 6,973 | 16,733 | -21,134 | -9,945 |
| Depreciation Amortization | 587 | 3,127 | 2,991 | 1,716 | 841 |
| Accounts receivable | -957 | -1,834 | -221 | -1,232 | 123 |
| Accounts payable and accrued liabilities | -3,371 | 195 | -1,941 | -5,139 | -4,916 |
| Other Working Capital | -4,488 | -4,496 | 2,833 | -8,356 | -4,750 |
| Other Operating Activity | 5,105 | -45,538 | -46,547 | 9,609 | 6,620 |
| Operating Cash Flow | $-16,978 | $-41,573 | $-26,152 | $-24,536 | $-12,027 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -473 | -1,402 | -1,105 | -970 | -794 |
| Net Acquisitions | 54 | 59,763 | 60,477 | N/A | N/A |
| Purchase Of Investment | -1,998 | -99,633 | -29,291 | -10,279 | -10,138 |
| Sale Of Investment | 25,929 | 70,730 | 53,218 | 29,189 | 8,102 |
| Investing Cash Flow | $23,512 | $29,458 | $83,299 | $17,940 | $-2,830 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 186 | 442 | N/A | -811 | N/A |
| Other Financing Activity | -742 | 19,092 | 19,007 | 20,000 | 19,195 |
| Financing Cash Flow | $-556 | $19,534 | $19,007 | $19,189 | $19,195 |
| Beginning Cash Position | 17,495 | 10,076 | 10,076 | 10,076 | 10,076 |
| End Cash Position | 23,473 | 17,495 | 86,230 | 22,669 | 14,414 |
| Net Cash Flow | $5,978 | $7,419 | $76,154 | $12,593 | $4,338 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,978 | -41,573 | -26,152 | -24,536 | -12,027 |
| Capital Expenditure | -473 | -1,402 | -1,105 | -970 | -794 |
| Free Cash Flow | -17,451 | -42,975 | -27,257 | -25,506 | -12,821 |